“These data demonstrate that CBDV, when administered chronically and starting at juvenile age, holds a solid therapeutic potential for FXS.”
Topic: Marijuana Research
Browse these news releases for articles that indicate laws or changes on how marijuana research is conducted. For articles about specific topics of “Research Studies” please choose that topic.
“To the best of our knowledge, this is the first study … regarding cannabis use in the medical context in ALS patients.”
Patients suffering from pain, cancer, anxiety, and insomnia show sustained benefits after commencing treatment with medical cannabis.
Authors concluded, “We found medical cannabis to be a safe and effective treatment option to help with cancer pain relief.”
“In this analysis, medicinal cannabis … appeared to be associated with significant improvements in pain intensity, pain interference, social functioning and pain impact scores,” researchers determined.
“[Our study] shows that the majority of participants reported an improvement in their subjective sleep symptoms since commencing medical cannabis,” investigators concluded.
“The results demonstrate that all terpenes, when tested individually, activate CB1 receptors, at about 10-50 percent of the activation by THC alone,” researchers affirmed.
On a scale of zero (totally ineffective) to 10 (totally effective), 69 percent of users rated the effectiveness of cannabis as 7 or higher at relieving pelvic pain.